ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in ProMIS Neurosciences Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- 0 vs. Q1 2024
- Shares held
- 3.26M
- −120.3K (−3.6%) vs. Q1 2024
- Total value
- $4.90M
- −$1.56M (−24.1%) vs. Q1 2024
- New holders
- 2
- 0 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $84.3M |
| Q1 2026 | 25 | $78.0M |
| Q4 2025 | 9 | $1.80M |
| Q3 2025 | 23 | $4.25M |
| Q2 2025 | 19 | $4.10M |
| Q1 2025 | 17 | $6.49M |
| Q4 2024 | 17 | $9.21M |
| Q3 2024 | 18 | $12.6M |
| Q2 2024 | 16 | $4.90M |
| Q1 2024 | 16 | $6.46M |
| Q4 2023 | 15 | $3.85M |
| Q3 2023 | 14 | $5.61M |
| Q2 2023 | 13 | $723.8K |
| Q1 2023 | 12 | $889.2K |
| Q4 2022 | 13 | $824.5K |
| Q3 2022 | 13 | $1.13M |
| Q2 2022 | 2 | $468.0K |
| Q1 2022 | 2 | $8.00K |
| Q4 2021 | 2 | $9.00K |
| Q3 2021 | 3 | $14.0K |
| Q2 2021 | 3 | $17.0K |
| Q1 2021 | 3 | $17.0K |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding ProMIS Neurosciences Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sphera Funds Management Ltd. | 1,814,213 | $2.72M | 0.44% | −19,834−1.1% | Reduced |
| Ally Bridge Group (NY) LLC | 1,059,582 | $1.59M | 0.95% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 265,958 | $398.9K | 0.06% | 00.0% | Unchanged |
| Bank of Montreal | 30,366 | $55.3K | 0.00% | 00.0% | Unchanged |
| Hara Capital LLC | 29,416 | $44.1K | 0.03% | 00.0% | Unchanged |
| Ieq Capital, LLC | 26,042 | $39.1K | 0.00% | 00.0% | Unchanged |
| Fiduciary Trust Co | 20,008 | $30.0K | 0.00% | 00.0% | Unchanged |
| Claret Asset Management Corp | 10,830 | $16.0K | 0.00% | 00.0% | Unchanged |
| Sandy Spring Bank | 3,300 | $4.95K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,666 | $2.50K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 713 | $1.00K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 333 | $501 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 133 | $202 | 0.00% | +133 | New |
| Wells Fargo & Company | 20 | $30 | 0.00% | +20 | New |
| Northwestern Mutual Wealth Management Co | 4 | $6 | 0.00% | −139−97.2% | Reduced |
| JPMorgan Chase & Co | 3 | $5 | 0.00% | −250−98.8% | Reduced |
| Northeast Financial Consultants Inc | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −250−100.0% | Sold out |